Shuo Ma

发表论文 148 篇 · 总被引 6330 次 · h-index 34

代表论文

Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia. (2023 · New England Journal of Medicine · 被引 176)
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study (2023 · The Lancet · 被引 144)
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma (2023 · Journal of Clinical Oncology · 被引 82)
Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL (2022 · Blood Advances · 被引 47)
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study (2023 · American journal of hematology/oncology · 被引 37)
Efficacy of Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Relapsed / Refractory Waldenström Macroglobulinemia: Results from the Phase 1/2 BRUIN Study (2022 · Blood · 被引 37)